Synthesis, <i>in vitro</i> and <i>in silico</i> anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives.

ABSTRACT: Aim: The aim of this study was the synthesis of steroid compounds with heterocyclic rings and good anticancer properties. Materials & methods: The synthesis, in silico and in vitro anticancer testing of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives was performed. Results: All synthesized compounds have shown promising results for, antiproliferative activity, relative binding affinities for the ligand binding domains of estrogen receptors α, β and androgen receptor, aromatase binding potential, and inhibition of AKR1C3 enzyme. Conclusion: 3-Benzyloxy (17E)-pycolinilidene derivative 9 showed the best antitumor potential against MDA-MB-231 cell line, an activity that can be explained by its moderate inhibition of AKR1C3. Molecula

SUBMITTER: Stevanovic MZ 

PROVIDER: S-EPMC11221553 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature